Wu, X., Li, J., Wang, D., Wu, J., Zou, D., Duan, W., Li, D., Yang, H., Wu, J., Xiong, Y., Yan, X., Li, X., Zhu, G., Sun, L., Li, Y., Liu, Q., Kang, Y., Wang, K., Zhang, J., Wang, L. (2026). A phase III CHIPRO study of chiauranib plus weekly paclitaxel for platinum-resistant or refractory ovarian cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.17_suppl.lba5504